Lupus Research Alliance News
Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET

Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine – have been thrust into the public spotlight despite the mounting scientific evidence that drug does not appear to improve clinical outcomes in patients with COVID-19. What has been talked about less is what the impact […] READ MORE

Remembering Betty Wold Johnson, A Major LRA Friend and Benefactor

May 2020 The entire Board of Trustees and staff of the Lupus Research Alliance (LRA) and Lupus Therapeutics (LT) mourn the passing of Betty Wold Johnson, one of our kindest and most generous benefactors, and beloved mother of Robert Wood “Woody” Johnson, IV, LRA’s Chairman Emeritus and the U.S. Ambassador to the UK. The family […] READ MORE

New Data Points Away from Hydroxychloroquine as COVID-19 Treatment

Updated April 23, 2020 The most commonly prescribed treatment for lupus, hydroxychloroquine (best known as Plaquenil) is not effective for treating COVID-19 according to a new study of 368 hospitalized patients in United States Veteran Administration medical centers. Led by Mr. Joseph Magagnoli, Dr. Siddharth Narendran and Dr. Felipe Pereira at University of South Carolina, […] READ MORE

Are Autoimmune Diseases Increasing in the US?

April 16, 2020 A recently published study led by Dr. Gregg Dinse provides compelling evidence that proteins found in many people with autoimmune diseases have become more common in Americans over time. Using blood samples taken from 14,211 people representative of the American population, the researchers found that these proteins, also known as anti-nuclear antibodies […] READ MORE

Research Shows Benefit to Starting Belimumab Sooner Rather Than Later

April 16, 2020 Treating people with lupus earlier with belimumab (Benlysta) may work better than as a last option according to a study just published in the well-respected journal Arthritis & Rheumatology  Researchers in Italy analyzed data from 466 people with lupus at 24 centers in Italy who were receiving belimumab intravenously.  They looked at […] READ MORE

Learn and connect with our community!